1. Narcolepsy-like symptoms triggered by lemborexant in the context of hyperactive delirium in a patient with bipolar depression: a case report.
- Author
-
Shibata S, Oda Y, Ohki N, Ikemizu Y, Hayatsu R, Hirose Y, and Iyo M
- Subjects
- Female, Humans, Orexin Receptor Antagonists adverse effects, Orexins, Pyridines, Pyrimidines, Bipolar Disorder complications, Bipolar Disorder drug therapy, Cataplexy, Delirium chemically induced, Narcolepsy drug therapy
- Abstract
Lemborexant is a dual orexin antagonist and is considered a safe and effective hypnotic. Dual orexin antagonists induce physiological sleep by blocking orexin receptors. Although the blockade of orexin signaling has triggered narcolepsy-like symptoms in rodents, there is currently no evidence of lemborexant inducing narcolepsy-like symptoms in humans. We describe the case of a 79-year-old Japanese woman with bipolar depression who experienced lemborexant-induced cataplexy and sleep attack. Her previous results on the Multiple Sleep Latency Test excluded the diagnosis of narcolepsy. She experienced narcolepsy-like symptoms on 2 occasions after she was administered lemborexant, in the context of hyperactive delirium, but not in a relaxed state. Her case suggests that lemborexant could trigger narcolepsy-like symptoms in patients with hyperactive delirium, even those with no history of narcolepsy. This case also emphasizes that clinicians must be very careful when they prescribe lemborexant to patients who experience hyperactive delirium., Citation: Shibata S, Oda Y, Ohki N, et al. Narcolepsy-like symptoms triggered by lemborexant in the context of hyperactive delirium in a patient with bipolar depression: a case report. J Clin Sleep Med . 2022;18(5):1459-1462., (© 2022 American Academy of Sleep Medicine.)
- Published
- 2022
- Full Text
- View/download PDF